Mesoblast Ltd (MSB.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | N/A | N/A | 4,107 | N/A | N/A |
| Income taxes - deferred | N/A | N/A | -212 | N/A | N/A |
| Accounts receivable | N/A | N/A | -2,506 | N/A | N/A |
| Other Working Capital | N/A | N/A | -2,472 | N/A | N/A |
| Other Operating Activity | 0 | 0 | -62,186 | 0 | 0 |
| Operating Cash Flow | $N/A | $N/A | $-63,269 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -680 | -271 | -264 | -157 | -1,647 |
| Sale Of Investment | 241 | 234 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -50 | -60 | -50 | -75 | 0 |
| Other Investing Activity | 609 | 0 | 120 | 0 | 0 |
| Investing Cash Flow | $120 | $-97 | $-194 | $-232 | $-1,647 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 0 | 51,919 | 0 |
| Debt Repayment | -9,765 | -13,522 | -2,656 | -58,246 | -2,931 |
| Common Stock Issued | 161,205 | 65,406 | 88,635 | 209 | 106,268 |
| Other Financing Activity | -4,104 | -11,632 | -11,477 | -3,752 | 11,129 |
| Financing Cash Flow | $147,336 | $40,252 | $74,502 | $-9,870 | $114,466 |
| Exchange Rate Effect | 1,089 | -55 | -168 | -550 | 1,415 |
| Beginning Cash Position | 62,960 | 71,318 | 60,447 | 136,881 | 129,328 |
| End Cash Position | 161,551 | 62,960 | 71,318 | 60,447 | 136,881 |
| Net Cash Flow | $97,502 | $-8,303 | $11,039 | $-75,884 | $6,138 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | -63,269 | N/A | N/A |
| Capital Expenditure | -730 | -331 | -314 | -232 | -1,647 |
| Free Cash Flow | -730 | -331 | -63,583 | -232 | -1,647 |